StonvexLoading…
StonvexStonvexStonvexCore line items from CPSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $112.33M | $434.47M | $325.06M | $216.64M |
Operating Income | $8.03M | $28.00M | $20.79M | $13.75M |
Net Income | $5.54M | $19.32M | $14.34M | $9.49M |
EPS (Diluted) | $0.24 | $0.80 | $0.59 | $0.39 |
Total Assets | $4.05B | $3.86B | $3.81B | $3.76B |
Total Liabilities | $3.74B | $3.55B | $3.50B | $3.46B |
Cash & Equivalents | $6.94M | $6.32M | $9.39M | $15.77M |
Free Cash Flow OCF − CapEx | $82.98M | $288.29M | $212.60M | $127.73M |
Shares Outstanding | 21.70M | 21.84M | 22.14M | 22.22M |